{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:47:48Z","timestamp":1649101668783},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s00108-004-1298-0","type":"journal-article","created":{"date-parts":[[2004,10,27]],"date-time":"2004-10-27T07:11:40Z","timestamp":1098861100000},"page":"1388-1394","source":"Crossref","is-referenced-by-count":0,"title":["Therapie entz\ufffdndlicher Nierenerkrankungen"],"prefix":"10.1007","volume":"45","author":[{"given":"J.","family":"Galle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.ajkd.2003.08.011","volume":"42","author":"Bagga","year":"2003","unstructured":"Bagga A, Hari P, Moudgil A, Jordan SC (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42: 1114?1120","journal-title":"Am J Kidney Dis"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","volume":"14","author":"Birck","year":"2003","unstructured":"Birck R, Warnatz K, Lorenz HM et al. (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14: 440?447","journal-title":"J Am Soc Nephrol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","volume":"15","author":"Booth","year":"2004","unstructured":"Booth A, Harper L, Hammad T et al. (2004) Prospective study of TNF{alpha} blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15: 717?721","journal-title":"J Am Soc Nephrol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","volume":"343","author":"Chan","year":"2000","unstructured":"Chan TM, Li FK, Tang CS et al. (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343: 1156?1162","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0272-6386(88)80079-9","volume":"11","author":"Couser","year":"1988","unstructured":"Couser WG (1988) Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11: 449?464","journal-title":"Am J Kidney Dis"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.V1081772","volume":"10","author":"Donadio","year":"1999","unstructured":"Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC (1999) The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol 10: 1772?1777","journal-title":"J Am Soc Nephrol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","volume":"16","author":"de Groot","year":"2001","unstructured":"de Groot K, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16: 2018?2027","journal-title":"Nephrol Dial Transplant"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/ndt\/gfh312","volume":"19","author":"du Buf-Vereijken","year":"2004","unstructured":"du Buf-Vereijken PWG, Wetzels JFM (2004) Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. Nephrol Dial Transplant 19: 2036?2043","journal-title":"Nephrol Dial Transplant"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"Edwards","year":"2004","unstructured":"Edwards JCW, Szczepanski L, Szechinski J et al. (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350: 2572?2581","journal-title":"N Engl J Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"Fauci","year":"1983","unstructured":"Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener?s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76?85","journal-title":"Ann Intern Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ndt\/18.2.241","volume":"18","author":"Floege","year":"2003","unstructured":"Floege J (2003) Evidence-based recommendations for immunosuppression in IgA nephropathy: handle with caution. Nephrol Dial Transplant 18: 241?245","journal-title":"Nephrol Dial Transplant"},{"key":"CR12","doi-asserted-by":"crossref","unstructured":"Grabensee B, Bach D, Heering P (2004) Immunsuppression in der Therapie der Glomerulonephritis. Internist (Berl) 38: 562?573","DOI":"10.1007\/PL00002646"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1523-1755.2001.0590041211.x","volume":"59","author":"Hebert","year":"2001","unstructured":"Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS, Rovin BH (2001) Renoprotection: one or many therapies? Kidney Int 59: 1211?1226","journal-title":"Kidney Int"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K et al., the European Vasculitis Study Group (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","volume":"10","author":"Nowack","year":"1999","unstructured":"Nowack R, G\u00f6bel U, Klooker P, Hergesell O, Andrassy K, Van der Woude FJ (1999) Mycophenolate mofetil for maintenance therapy of Wegener?s granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10: 1965?1971","journal-title":"J Am Soc Nephrol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","volume":"14","author":"Ruggenenti","year":"2003","unstructured":"Ruggenenti P, Chiurchiu C, Brusegan V, Abbate M (2003) Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 14: 1851?1859","journal-title":"J Am Soc Nephrol"},{"key":"CR17","doi-asserted-by":"crossref","unstructured":"Schmidt U, Franke J, Thomae U, Mann J (2002) Glomerulonephritis. Internist (Berl) 43: 749?756","DOI":"10.1007\/s00108-002-0581-1"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","volume":"65","author":"Schmitt","year":"2004","unstructured":"Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ (2004) Treatment of refractory Wegener?s granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients. Kidney Int 65: 1440?1448","journal-title":"Kidney Int"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","volume":"44","author":"Specks","year":"2001","unstructured":"Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener?s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44: 2836?2840","journal-title":"Arthritis Rheum"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO;2-F","volume":"44","author":"Stone","year":"2001","unstructured":"Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS (2001) Etanercept combined with conventional treatment in Wegener?s granulomatosis: a six-month open-label trial to evaluate safety. Arthritis Rheum 44: 1149?1154","journal-title":"Arthritis Rheum"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-004-1298-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1298-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:38:40Z","timestamp":1624754320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-004-1298-0"}},"subtitle":["Mehr als Steroide?"],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1007\/s00108-004-1298-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}